Adam K. Simpson is CEO at Icosavax, Inc. (ICVX). They have made 2 open-market trades across 1 company since 2022, most recently 2024-02-19.
CIK 0001873839
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ICVX | 525,044 | $8.0M |
Shares reported on the most recent Form 4, priced at the 2024-02-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICVX | SELL · 10b5-1 | 2024-02-01 | 2024-02-02 | $15.29 | $229K | +0.9% | N/A | N/A |
| ICVX | SELL · 10b5-1 | 2024-01-02 | 2024-01-04 | $15.67 | $235K | -0.2% | -2.7% | N/A |
| ICVX | SELL · 10b5-1 | 2023-12-20 | 2023-12-22 | $15.45 | $3.3M | +0.5% | -1.5% | N/A |
| ICVX | SELL · 10b5-1 | 2023-07-31 | 2023-08-01 | $8.86 | $209K | -8.8% | -9.2% | -27.3% |
| ICVX | SELL | 2023-02-13 | 2023-02-15 | $10.69 | $160K | -11.0% | -30.3% | -10.3% |
| ICVX | SELL | 2022-12-21 | 2022-12-23 | $8.96 | $1.2M | -21.6% | -8.2% | -43.6% |
| ICVX | SELL · 10b5-1 | 2022-07-29 | 2022-08-02 | $6.75 | $77K | +28.3% | -34.4% | -51.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.